RCT Links $333 Monthly Cash to Modest Slowing of Epigenetic Aging Markers in Low-Income Children

The Baby's First Years study randomized mothers to high or low monthly cash with no conditions attached. Researchers assayed DNA methylation at age four to derive an epigenetic clock sensitive to stress and nutrition. The higher transfer group showed a modest shift consistent with slower biological aging, while mothers themselves exhibited no detectable difference. Prior waves of the same trial documented increased spending on child activities and altered EEG patterns but no broad gains in cognitive or behavioral scores.

This design isolates income as the active variable, addressing a gap left by observational studies that cannot rule out selection. The effect size remains small and its link to adult disease risk untested at this age. Related work in the same cohort and in conditional cash programs in low-resource settings suggests early windows matter more for biological embedding than later interventions.

Persistence is the central open question. If the epigenetic shift attenuates by middle childhood, policy weight should shift toward sustained transfers rather than time-limited early boosts. Continued follow-up through adolescence will be required to test whether the observed marker predicts later health endpoints or merely reflects transient state.